Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIKS - Acute Performance Of a Drug Eluting Absorbable Metal Scaffold (DREAMS 2G) in Patients With de Novo Lesions in NatiVE Coronary Arteries: BIOSOLVE-III

NCT02716220 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.

NCT NCT02716220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02716220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIKS - Acute Performance Of a Drug Eluting Absorbable Metal Scaffold (DREAMS 2G) in Patients With de Novo Lesions in NatiVE Coronary Arteries: BIOSOLVE-III
Lead sponsor
Biotronik AG
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
August 31, 2019
Enrollment
61 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery stenosis